Press
Highlights
News
Here you will find the latest publications related to the companies that are part of the Peaches Biotech group.
Each article contains the link to the page where the news is published.
The American Association of Cancer research has elected Manuel Hidalgo new member of the Board of Directors
The American Association of Cancer Research Board of Directors consists of world-renowned leaders in all areas of cancer research. Manuel Hidalgo, together with other four individuals, have been elected to the AACR Board of Directors for the 2024-2027 term: Manuel...
Meeting Peaches Biotech
Interview with Juan Carlos de Gregorio, Peaches CEO The publication specialised in biotechnology, Farmabiotec, has given us the opportunity to share our opinion as science researchers of the present and future of biotechnology. Juan Carlos de Gregorio, founder and CEO...
Peaches Biotech receives the Innova Health 2023 Award for the most innovative project.
A RECOGNITION OF THE COMPANY, ITS PROFESSIONALS AND THE ADVANCES ACHIEVED IN ITS SECRETOME-BASED THERAPIES The recently held Innova Health 2023 Congress, whose main objective is to address the main challenges faced by healthcare systems around the world, is also known...
The secretome as 21st century medicine
FIRST CONFERENCE AUTONOMOUS UNIVERSITY OF MADRID AND PEACHES DEMONSTRATES THE SUCCESSFUL UNION OF OUR RESEARCH FORCES, THE ACADEMIC, UNIVERSIDAD AUTÓNOMA DE MADRID, AND THE INDUSTRY, PEACHES BIOTECH - The UAM-PEACHES Chair in Cellular Therapies at the Autonomous...
Peaches Biotech receives 598,000 euros from the CDTI for its PRS project on advanced therapies
The Center for Technological Development and Innovation (CDTI), of the Ministry of Science and Innovation, has approved a project of the Spanish company Peaches Biotech, considering it highly innovative, providing it with 598,000 euros. The selected research...
Peaches Biotech, the Universidad Autónoma of Madrid (UAM) and its Foundation create the first University Chair in Advanced Therapies
We have created with the Universidad Autónoma of Madrid (UAM) and its Foundation (FUSM) the first University Chair in Advanced Therapies based on cell secretomes The UAM-Peaches Chair will promote research and teaching in the areas of Cellular Therapy and Regenerative...
Peaches obtains financial approval from the Ministry of Science and Innovation for two of its advanced therapy projects
PRESS RELEASE Peaches has the demanding scientific and technological recognition of AEI The State Research Agency (AEI) of the Ministry of Science and Innovation approves funding for two Peaches Biotech projects in its call for public-private collaboration. The...
International Cancer Research Day
We share with you this interesting interview in Con Salud, one of the leading media in the health sector, about our novel and promising approach to pancreatic cancer treatment. Juan Carlos de Gregorio, our CEO and founder, explains in plain language the advances...
A new approach for the treatment of infection-associated cytokine storm.
Did you know that cytokine storm, associated with severe infectious processes, is a serious global health problem for which there is no effective drug for treatment? Peaches Biotech's Chief Scientific Officer publishes results of his research against the cytokine...
LOCATION
C/ Isabel Colbrand 6
4ª Planta B
28050 Madrid (Spain)
OPENING HOURS
L - J : 9:00–18:00 hs
V : 9:00–15:00 hs